GB9108348D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9108348D0
GB9108348D0 GB919108348A GB9108348A GB9108348D0 GB 9108348 D0 GB9108348 D0 GB 9108348D0 GB 919108348 A GB919108348 A GB 919108348A GB 9108348 A GB9108348 A GB 9108348A GB 9108348 D0 GB9108348 D0 GB 9108348D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919108348A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon Health Science University
Oregon State University
Oregon State
Original Assignee
Oregon Health Science University
Oregon State University
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon Health Science University, Oregon State University, Oregon State filed Critical Oregon Health Science University
Priority to GB919108348A priority Critical patent/GB9108348D0/en
Publication of GB9108348D0 publication Critical patent/GB9108348D0/en
Priority to IL101455A priority patent/IL101455A0/en
Priority to MX9201791A priority patent/MX9201791A/en
Priority to PCT/US1992/003094 priority patent/WO1992018118A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB919108348A 1991-04-18 1991-04-18 Medicaments Pending GB9108348D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB919108348A GB9108348D0 (en) 1991-04-18 1991-04-18 Medicaments
IL101455A IL101455A0 (en) 1991-04-18 1992-04-02 Pharmaceutical compositions containing a methylthioribose kinase inhibitor
MX9201791A MX9201791A (en) 1991-04-18 1992-04-15 MEDICINES.
PCT/US1992/003094 WO1992018118A1 (en) 1991-04-18 1992-04-15 Medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919108348A GB9108348D0 (en) 1991-04-18 1991-04-18 Medicaments

Publications (1)

Publication Number Publication Date
GB9108348D0 true GB9108348D0 (en) 1991-06-05

Family

ID=10693536

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919108348A Pending GB9108348D0 (en) 1991-04-18 1991-04-18 Medicaments

Country Status (4)

Country Link
GB (1) GB9108348D0 (en)
IL (1) IL101455A0 (en)
MX (1) MX9201791A (en)
WO (1) WO1992018118A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180714A (en) * 1990-10-31 1993-01-19 Health Research, Inc. Adenosine compounds for the treatment of diseases caused by parasitic protozoa
WO2010010383A1 (en) * 2008-07-21 2010-01-28 Isis Innovation Limited Treatment of obesity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820692A (en) * 1986-01-30 1989-04-11 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And Oregon State University Methylthioribose analogs, their preparation and use as medicinal agents and biocides

Also Published As

Publication number Publication date
WO1992018118A1 (en) 1992-10-29
MX9201791A (en) 1992-10-01
IL101455A0 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
OA09926A (en) Medicaments
AP9200403A0 (en) Medicaments
AP9100339A0 (en) Medicaments
GB9121204D0 (en) Medicament
GB9115740D0 (en) Medicaments
GB9121463D0 (en) Medicament
GB9122051D0 (en) Medicines
GB9108348D0 (en) Medicaments
GB9104650D0 (en) Medicaments
ZA927925B (en) Medicaments
GB9111901D0 (en) Medicaments
GB9113383D0 (en) Medicaments
GB9113787D0 (en) Medicaments
GB9116687D0 (en) Medicaments
GB9117943D0 (en) Medicaments
GB9122472D0 (en) Medicaments
GB9122473D0 (en) Medicaments
GB9122475D0 (en) Medicaments
GB9123597D0 (en) Medicaments
GB9126027D0 (en) Medicaments
GB9126378D0 (en) Medicaments
GB9126405D0 (en) Medicaments
GB9126444D0 (en) Medicaments
GB9113381D0 (en) Medicaments
GB9113377D0 (en) Medicaments